BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 27824810)

  • 1. Predicting poor prognosis recurrence in women with endometrial cancer: a nomogram developed by the FRANCOGYN study group.
    Ouldamer L; Bendifallah S; Body G; Touboul C; Graesslin O; Raimond E; Collinet P; Coutant C; Lavoué V; Lévêque J; Daraï E; Ballester M
    Br J Cancer; 2016 Nov; 115(11):1296-1303. PubMed ID: 27824810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integration of pretreatment tumor markers in a nomogram model for prognostic prediction of FIGO stage I endometrial cancer: A multi-institutional cohort study.
    Lin H; Wu CH; Ou YC; Huang SW; Fu HC
    Int J Gynaecol Obstet; 2024 Jun; 165(3):1244-1256. PubMed ID: 38287783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Predictive Model Using Histopathologic Characteristics of Early-Stage Type 1 Endometrial Cancer to Identify Patients at High Risk for Lymph Node Metastasis.
    Bendifallah S; Canlorbe G; Laas E; Huguet F; Coutant C; Hudry D; Graesslin O; Raimond E; Touboul C; Collinet P; Cortez A; Bleu G; Daraï E; Ballester M
    Ann Surg Oncol; 2015 Dec; 22(13):4224-32. PubMed ID: 25869227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validating the 2023 FIGO staging system: A nomogram for endometrioid endometrial cancer and adenocarcinoma.
    Feng Y; Miao F; Li Y; Li M; Cao Y
    Cancer Med; 2024 May; 13(10):e7216. PubMed ID: 38752451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Web-based nomogram predicting para-aortic nodal metastasis in incompletely staged patients with endometrial cancer: a Korean Multicenter Study.
    Kang S; Lee JM; Lee JK; Kim JW; Cho CH; Kim SM; Park SY; Park CY; Kim KT
    Int J Gynecol Cancer; 2014 Mar; 24(3):513-9. PubMed ID: 24552891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A nomogram for predicting overall survival in patients with low-grade endometrial stromal sarcoma: A population-based analysis.
    Wu J; Zhang H; Li L; Hu M; Chen L; Xu B; Song Q
    Cancer Commun (Lond); 2020 Jul; 40(7):301-312. PubMed ID: 32558385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic nomogram for predicting survival in patients with high grade endometrial stromal sarcoma: a Surveillance Epidemiology, and End Results database analysis.
    Wu J; Zhang H; Li L; Hu M; Chen L; Wu S; Xu B; Song Q
    Int J Gynecol Cancer; 2020 Oct; 30(10):1520-1527. PubMed ID: 32839227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Nomogram for Predicting Progression-free Survival in Patients with Endometrial Cancer.
    Wang Z; Zhao Z; Li W; Bao X; Liu T; Yang X
    Clin Oncol (R Coll Radiol); 2023 Sep; 35(9):e516-e527. PubMed ID: 37230875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A nomogram for predicting overall survival in patients with type II endometrial carcinoma: a retrospective analysis and multicenter validation study.
    Ren X; Wang MM; Wang G; Sun XM; Xia TT; Yao Y; Wang CC; Jiang AF; Wang H; Cao J; Wei YJ; Sun CG
    Eur Rev Med Pharmacol Sci; 2023 Jan; 27(1):233-247. PubMed ID: 36647873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nomograms based on the novel platelet index score predict postoperative prognosis in endometrial cancer.
    Chen H; Wu Q; Zhang Y; Li Q; Ma J; Kong F; Ma X
    Gynecol Oncol; 2020 Sep; 158(3):689-697. PubMed ID: 32507649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A nomogram for predicting lymph node metastasis of presumed stage I and II endometrial cancer.
    Bendifallah S; Genin AS; Naoura I; Chabbert Buffet N; Clavel Chapelon F; Haddad B; Luton D; Darai E; Rouzier R; Koskas M
    Am J Obstet Gynecol; 2012 Sep; 207(3):197.e1-8. PubMed ID: 22939725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Competing risk nomogram predicting cancer-specific mortality for endometrial cancer patients treated with hysterectomy.
    Xie G; Qi C; Yang W; Wang R; Yang L; Shang L; Huang L; Chung MC
    Cancer Med; 2021 May; 10(10):3205-3213. PubMed ID: 33932121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nomogram for Predicting Recurrence-Free Survival in Chinese Women with Endometrial Cancer after Initial Therapy: External Validation.
    Cheng Y; Dong Y; Tian W; Zhang H; Li X; Wang Z; Shan B; Ren Y; Wei L; Wang H; Wang J
    J Oncol; 2020; 2020():2363545. PubMed ID: 32565798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MRI-based traditional radiomics and computer-vision nomogram for predicting lymphovascular space invasion in endometrial carcinoma.
    Long L; Sun J; Jiang L; Hu Y; Li L; Tan Y; Cao M; Lan X; Zhang J
    Diagn Interv Imaging; 2021; 102(7-8):455-462. PubMed ID: 33741266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and validation of a prognostic nomogram for 2018 FIGO stages IB1, IB2, and IIA1 cervical cancer: a large multicenter study.
    Chen X; Duan H; Liu P; Lin L; Ni Y; Li D; Dai E; Zhan X; Li P; Huo Z; Bin X; Lang J; Chen C
    Ann Transl Med; 2022 Jan; 10(2):121. PubMed ID: 35282114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of a nomogram for predicting overall survival in patients with early-onset endometrial cancer.
    Zhang M; Li R; Zhang J; Wang Y; Wang Y; Guo Y
    BMC Cancer; 2023 Dec; 23(1):1230. PubMed ID: 38097995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic and prognostic factors, and two nomograms for endometrial cancer patients with bone metastasis: A large cohort retrospective study.
    Yang F; Zhao R; Huang X; Wang Y
    Medicine (Baltimore); 2021 Sep; 100(36):e27185. PubMed ID: 34516519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of a prognostic nomogram for predicting cancer-specific survival in advanced endometrial carcinoma after surgery: a retrospective analysis of the SEER Database.
    Zheng C; Chen W; Zheng Z; Liang X; Xu X; Fang D; Ma R; Fan F; Ni Y; Zhang P; Wu X
    BMJ Open; 2023 Sep; 13(9):e070893. PubMed ID: 37714671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk-scoring models for individualized prediction of overall survival in low-grade and high-grade endometrial cancer.
    AlHilli MM; Mariani A; Bakkum-Gamez JN; Dowdy SC; Weaver AL; Peethambaram PP; Keeney GL; Cliby WA; Podratz KC
    Gynecol Oncol; 2014 Jun; 133(3):485-93. PubMed ID: 24690476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and validation of a nomogram involving immunohistochemical markers for prediction of recurrence in early low-risk endometrial cancer.
    Kong W; Tu Y; Jiang P; Huang Y; Zhang J; Jiang S; Li N; Yuan R
    Int J Biol Markers; 2022 Dec; 37(4):395-403. PubMed ID: 36250543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.